Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dihydropyrazothiazole derivatives as potential MMP-2/MMP-8 inhibitors for cancer therapy

Published:2018-12 Issue:23-24 Volume:28 Page:3816-3821
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Wang Zhong-Chang,Shen Fa-Qian,Yang Meng-Ru,You Ling-Xia,Chen Li-Zhi,Zhu Hai-Liang^ORCID,Lu Ya-Dong,Kong Fan-Lei,Wang Ming-Hua

Funder

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference38 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. The decline in cancer mortality in the European Union, 1988–1996;Levi;Eur J Cancer,1965

3. Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities;Kuo;Antioxid Redox Signaling,2009

4. Blockade of asparagine endopeptidase inhibits cancer metastasis;Qi;J Med Chem,2017

5. Design and therapeutic application of matrix metalloproteinase inhibitors;Whittaker;Chem Rev,2001

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pinpointing prime structural attributes of potential MMP-2 inhibitors comprising alkyl/arylsulfonyl pyrrolidine scaffold: a ligand-based molecular modelling approach validated by molecular dynamics simulation analysis;SAR and QSAR in Environmental Research;2024-08-02

2. Targeted Development of Pyrazoline Derivatives for Neurological Disorders: A Review;ChemistrySelect;2024-04-23

3. Development in the Synthesis of Bioactive Thiazole-Based Heterocyclic Hybrids Utilizing Phenacyl Bromide;ACS Omega;2024-04-16

4. Discovery of matrix metalloproteinase inhibitors as anti-skin photoaging agents;European Journal of Medicinal Chemistry;2024-03

5. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023);Molecules;2023-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3